We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Isle of Man’s GLO wants to sell 25 per cent to clients, letting them influence production
Error prompts life assurance customers to pause or review relationship with early detection biotech
Marketing attractive nicotine products to children risks a whole generation’s health
Regulators might put up an obstacle given the Swedish group’s sizeable footprint in the sector
Move for veterinary pharma company would represent one of biggest UK private equity deals this year
Scientists apply deep learning to expanded DNA database to help identify disease-causing mutations in humans
The tobacco company can justifiably claim expertise in developing alternative products that smokers will actually try
Generative AI has uses for the legal and health professions but is also a trap for the unwary
The leaked draft of the WHO Pandemic Accord contains worrying signs
Policy prescriptions are plentiful but momentum and money behind them is lacking
Is this legal manoeuvre setting a precedent for corporations to evade accountability in America?
Appeals court says some liability releases are ‘appropriate’ under US bankruptcy law
Despite increasing staff numbers, services in England are struggling to match pre-pandemic treatment levels
Rise in temperatures has led to the spread of disease-carriers to higher altitudes
World’s biggest gene sequencing company rejects EU’s fast- track application
Revised contract addresses concerns over costly glut of unwanted shots as public health threat wanes
UK unveils reforms worth £650mn to boost the life sciences sector
Vote to remove John Thompson is the culmination of one of the largest shareholder activism campaigns in years
Entrepreneurial flair continues to be key feature of continent’s economic dynamism
Continent’s rising demographics present an opportunity for private providers
Government seeks to win over pharma groups with new investments in genomics research and drug manufacturing
As McDonald’s is targeted, governments also need to tighten and enforce rules
Independent data shows record number of UK patients paying for treatment
The FT examines the causes and effects of an increasing global resistance to antibiotics: from the pressures doctors are under to prescribe them, to what new treatments are currently in the pipeline, as well as what role can the consumer play in reducing antibiotic use in the food chain
Governments and some pharma companies try to tackle problem linked with drug resistance
International Edition
